Tandem Diabetes Care Q2 2024 10-Q Filed
Ticker: TNDM · Form: 10-Q · Filed: 2024-08-01T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, quarterly-report, healthcare
TL;DR
Tandem Diabetes Care filed its Q2 2024 10-Q, showing updated financials and business operations.
AI Summary
Tandem Diabetes Care, Inc. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the second quarter of 2024. Key financial data and business segments are presented, reflecting the company's ongoing activities in the diabetes care market.
Why It Matters
This filing provides investors and stakeholders with the latest financial and operational details for Tandem Diabetes Care, crucial for understanding the company's performance and future outlook in the medical device sector.
Risk Assessment
Risk Level: medium — The filing is a routine quarterly report, but the medical device industry and specific company performance can carry inherent risks.
Key Numbers
- 20240630 — Period End Date (Financial reporting period)
- 20240801 — Filing Date (Date the report was submitted to the SEC)
Key Players & Entities
- TANDEM DIABETES CARE INC (company) — Filer
- 20240630 (date) — Period of Report
- San Diego (location) — Business Address City
- 858-366-6900 (phone_number) — Business Phone
FAQ
What is the reporting period for this 10-Q filing?
The Conformed Period of Report is 20240630, indicating the second quarter of 2024.
What is the company's primary business address?
The company's business address is 12400 HIGH BLUFF DRIVE, San Diego, CA 92130.
What is the SEC file number for Tandem Diabetes Care Inc.?
The SEC file number is 001-36189.
When was this 10-Q filing submitted?
The filing was submitted on 20240801.
What is the Standard Industrial Classification for Tandem Diabetes Care Inc.?
The SIC code is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
From the Filing
0001438133-24-000177.txt : 20240801 0001438133-24-000177.hdr.sgml : 20240801 20240801161156 ACCESSION NUMBER: 0001438133-24-000177 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 88 CONFORMED PERIOD OF REPORT: 20240630 FILED AS OF DATE: 20240801 DATE AS OF CHANGE: 20240801 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TANDEM DIABETES CARE INC CENTRAL INDEX KEY: 0001438133 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 204327508 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-36189 FILM NUMBER: 241166812 BUSINESS ADDRESS: STREET 1: 12400 HIGH BLUFF DRIVE CITY: San Diego STATE: CA ZIP: 92130 BUSINESS PHONE: 858-366-6900 MAIL ADDRESS: STREET 1: 12400 HIGH BLUFF DRIVE CITY: San Diego STATE: CA ZIP: 92130 10-Q 1 tndm-20240630.htm 10-Q tndm-20240630 false 2024 Q2 0001438133 12/31 0.0289361 0.0088836 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure tndm:trading_day tndm:segment iso4217:CHF tndm:lawsuit 0001438133 2024-01-01 2024-06-30 0001438133 2024-07-29 0001438133 2024-06-30 0001438133 2023-12-31 0001438133 2024-04-01 2024-06-30 0001438133 2023-04-01 2023-06-30 0001438133 2023-01-01 2023-06-30 0001438133 us-gaap:CommonStockMember 2024-03-31 0001438133 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001438133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001438133 us-gaap:RetainedEarningsMember 2024-03-31 0001438133 2024-03-31 0001438133 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001438133 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001438133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0001438133 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001438133 us-gaap:CommonStockMember 2024-06-30 0001438133 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001438133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001438133 us-gaap:RetainedEarningsMember 2024-06-30 0001438133 us-gaap:CommonStockMember 2023-12-31 0001438133 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001438133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001438133 us-gaap:RetainedEarningsMember 2023-12-31 0001438133 us-gaap:CommonStockMember 2024-01-01 2024-06-30 0001438133 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-06-30 0001438133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-06-30 0001438133 us-gaap:RetainedEarningsMember 2024-01-01 2024-06-30 0001438133 us-gaap:CommonStockMember 2023-03-31 0001438133 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001438133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001438133 us-gaap:RetainedEarningsMember 2023-03-31 0001438133 2023-03-31 0001438133 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001438133 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001438133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0001438133 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001438133 us-gaap:CommonStockMember 2023-06-30 0001438133 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001438133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001438133 us-gaap:RetainedEarningsMember 2023-06-30 0001438133 2023-06-30 0001438133 us-gaap:CommonStockMember 2022-12-31 0001438133 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001438133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001438133 us-gaap:RetainedEarningsMember 2022-12-31 0001438133 2022-12-31 0001438133 us-gaap:CommonStockMember 2023-01-01 2023-06-30 0001438133 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-06-30 0001438133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-06-30 0001438133 us-gaap:RetainedEarningsMember 2023-01-01 2023-06-30 0001438133 tndm:InsulinPumpMember srt:MinimumMember 2024-01-01 2024-06-30 0001438133 us-gaap:Convert